Medtronic on Tuesday reported an increase in first quarter revenue for the 2018 fiscal year, which ended July 28.
Here are five things to know.
- The drugmaker's revenue jumped to $7.39 billion, marking a 3.1 percent increase from quarter one of fiscal year 2017.
- Sales for Medtronic's cardiac and vascular business increased 5.1 percent year over year to $2.65 billion. The unit accounted for almost 36 percent of the company's total sales.
- Net income increased from $929 million in the first quarter of 2017 to $1.02 billion in the first quarter of 2018.
- Medtronic said the global computer outage it experienced in June had "some impact" on overall quarterly performance, but was not material to earnings or revenue, according to CNBC.
- The drugmaker maintained its full-year earnings and revenue forecasts, projecting adjusted earnings per share will increase 9 percent to 10 percent and revenue to rise 4 percent to 5 percent for the fiscal year ending in April 2018.
More articles on supply chain:
7 must-reads for supply chain leaders this week
Mylan finalizes $465 million settlement with DOJ over EpiPen rebates
CDC: Yellow fever vaccine out of stock